GenoFocus Inc (KQ:187420) — Market Cap & Net Worth
Market Cap & Net Worth: GenoFocus Inc (187420)
GenoFocus Inc (KQ:187420) has a market capitalization of $43.83 Million (₩64.68 Billion) as of June 17, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22471 globally and #1429 in its home market, demonstrating a 2.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GenoFocus Inc's stock price ₩2220.00 by its total outstanding shares 29135882 (29.14 Million). Review how much debt does GenoFocus Inc carry to assess the company's total debt and financial obligations.
GenoFocus Inc Market Cap History: 2015 to 2026
GenoFocus Inc's market capitalization history from 2015 to 2026. Data shows change from $182.15 Million to $43.83 Million (-14.19% CAGR).
Index Memberships
GenoFocus Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$279.47 Billion | 0.02% | #698 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$279.47 Billion | 0.02% | #698 of 1384 |
Weight: GenoFocus Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GenoFocus Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GenoFocus Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
GenoFocus Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
GenoFocus Inc's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $192.02 Million | $7.03 Billion | $1.61 Billion | 0.03x | 0.12x |
| 2017 | $204.36 Million | $11.51 Billion | $1.41 Billion | 0.02x | 0.14x |
| 2018 | $139.00 Million | $11.52 Billion | -$2.32 Billion | 0.01x | N/A |
| 2019 | $112.55 Million | $14.94 Billion | -$5.76 Billion | 0.01x | N/A |
| 2020 | $217.19 Million | $18.77 Billion | -$12.22 Billion | 0.01x | N/A |
| 2021 | $161.32 Million | $25.87 Billion | -$6.82 Billion | 0.01x | N/A |
| 2022 | $107.61 Million | $27.80 Billion | -$12.97 Billion | 0.00x | N/A |
| 2023 | $77.10 Million | $27.01 Billion | -$2.95 Billion | 0.00x | N/A |
| 2024 | $88.06 Million | $35.43 Billion | -$18.83 Billion | 0.00x | N/A |
| 2025 | $52.32 Million | $43.37 Billion | $22.59 Billion | 0.00x | 0.00x |
Competitor Companies of 187420 by Market Capitalization
Companies near GenoFocus Inc in the global market cap rankings as of June 17, 2026.
Key companies related to GenoFocus Inc by market ranking:
- Linde plc Ordinary Shares (NASDAQ:LIN): Ranked #95 globally with a market cap of $210.18 Billion USD.
- AIR LIQUIDE ADR 1/5/EO 11 (F:AILA): Ranked #243 globally with a market cap of $103.86 Billion USD ( €88.84 Billion EUR).
- Air Liquide SA (PA:AI): Ranked #253 globally with a market cap of $101.06 Billion USD ( €86.44 Billion EUR).
- Sherwin-Williams Co (NYSE:SHW): Ranked #333 globally with a market cap of $79.39 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #95 | Linde plc Ordinary Shares | NASDAQ:LIN | $210.18 Billion | $521.48 |
| #243 | AIR LIQUIDE ADR 1/5/EO 11 | F:AILA | $103.86 Billion | €36.60 |
| #253 | Air Liquide SA | PA:AI | $101.06 Billion | €165.86 |
| #333 | Sherwin-Williams Co | NYSE:SHW | $79.39 Billion | $320.24 |
GenoFocus Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, GenoFocus Inc's market cap moved from $182.15 Million to $ 43.83 Million, with a yearly change of -14.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩43.83 Million | -16.23% |
| 2025 | ₩52.32 Million | -40.58% |
| 2024 | ₩88.06 Million | +14.21% |
| 2023 | ₩77.10 Million | -28.35% |
| 2022 | ₩107.61 Million | -33.29% |
| 2021 | ₩161.32 Million | -25.73% |
| 2020 | ₩217.19 Million | +92.98% |
| 2019 | ₩112.55 Million | -19.03% |
| 2018 | ₩139.00 Million | -31.98% |
| 2017 | ₩204.36 Million | +6.43% |
| 2016 | ₩192.02 Million | +5.42% |
| 2015 | ₩182.15 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of GenoFocus Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $43.83 Million USD |
| MoneyControl | $43.83 Million USD |
| MarketWatch | $43.83 Million USD |
| marketcap.company | $43.83 Million USD |
| Reuters | $43.83 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GenoFocus Inc
HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phy… Read more